iPremom raised €15 million to clinically validate and commercially roll out its MaiRa early pregnancy-complications testing platform.
- Amount
- $17.4M
- Stage
- Seed
- Announced
- 2 September 2026
- Investors
- Amadeus Capital Partners, Asabys Partners, APEX Ventures
- Checked
- Amount and date matched across 2 press sources